Javier López-Belmonte Encina
Director of Finance/CFO chez LABORATORIOS FARMACEUTICOS ROVI, S.A.
Profil
Actuellement, Javier Lpez-Belmonte Encina occupe le poste de directeur général et secrétaire de Norbepa Inversiones, S.l., vice-président et directeur financier de Laboratorios Farmaceticos Rovi SA, directeur et secrétaire adjoint d'Alentia Biotech SLU (filiale de Laboratorios Farmaceticos Rovi SA) et secrétaire et directeur d'Enervit Nutrition SL. Il est également directeur et secrétaire adjoint d'Alentia Biotech SLU, membre du conseil social de l'université autonome de Madrid et membre du conseil d'administration de six autres sociétés. Dans le passé, Javier Lpez-Belmonte Encina a occupé le poste d'analyste chez Argentaria SA. Il a obtenu un diplôme de premier cycle du Colegio Universitario de Estudios Financieros et un MBA de l'université de Brown.
Postes actifs de Javier López-Belmonte Encina
Sociétés | Poste | Début |
---|---|---|
LABORATORIOS FARMACEUTICOS ROVI, S.A. | Director of Finance/CFO | 01/01/2001 |
Inversiones Clidia SL
Inversiones Clidia SL Pharmaceuticals: MajorHealth Technology Inversiones Clidia SL is a holding Spanish company with interests in the pharmaceutical sector. The private company is based in Madrid, Spain. | Director/Board Member | - |
Norbepa Inversiones, S.l. | Chief Executive Officer | - |
Lobel Y Losa Development SL | Director/Board Member | - |
Inversiones Borbollon SL | Director/Board Member | - |
Alentia Biotech SLU | Director/Board Member | - |
Norbel Inversiones SL
Norbel Inversiones SL Pharmaceuticals: MajorHealth Technology Norbel Inversiones SL is based in Madrid, Spain and has subsidiaries in Germany, Spain, and France. The Spanish company specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company's diverse product portfolio includes diagnostic imaging products and other hospital supplies. Norbel Inversiones SL is a pharmaceutical company founded in 2015. | Director/Board Member | - |
Confederación Empresarial de Madrid | Corporate Officer/Principal | - |
Avalmadrid S.G.R | Director/Board Member | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Javier López-Belmonte Encina
Sociétés | Poste | Fin |
---|---|---|
░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Javier López-Belmonte Encina
Brown University | Masters Business Admin |
Colegio Universitario de Estudios Financieros | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LABORATORIOS FARMACEUTICOS ROVI, S.A. | Health Technology |
Entreprise privées | 11 |
---|---|
Argentaria SA | Finance |
Avalmadrid S.G.R | |
Inversiones Clidia SL
Inversiones Clidia SL Pharmaceuticals: MajorHealth Technology Inversiones Clidia SL is a holding Spanish company with interests in the pharmaceutical sector. The private company is based in Madrid, Spain. | Health Technology |
Confederación Empresarial de Madrid | |
Norbepa Inversiones, S.l. | |
Lobel Y Losa Development SL | |
Inversiones Borbollon SL | |
Alentia Biotech SLU | |
Norbel Inversiones SL
Norbel Inversiones SL Pharmaceuticals: MajorHealth Technology Norbel Inversiones SL is based in Madrid, Spain and has subsidiaries in Germany, Spain, and France. The Spanish company specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company's diverse product portfolio includes diagnostic imaging products and other hospital supplies. Norbel Inversiones SL is a pharmaceutical company founded in 2015. | Health Technology |
Enervit Nutrition SL
Enervit Nutrition SL Food DistributorsDistribution Services Enervit Nutrition SL is a Spanish company that distributes Enervit products. The private company is based in Madrid, Spain. The CEO of the company is Iván López-Belmonte Encina. | Distribution Services |
Fundación Universidad Autonoma De Madrid |